Metabolomics Profiling and Diagnosis Biomarkers Searching for Drug-Induced Liver Injury Implicated to : A Cross-Sectional Cohort Study
Overview
Authors
Affiliations
The diagnosis of drug-induced liver injury (DILI) remains a challenge and the cases of Thunb. (PM) induced DILI (PM-DILI) have received much attention This study aimed to identify a simple and high-efficiency approach to PM-DILI diagnosis via metabolomics analysis. Plasma metabolites in 13 PM-DILI patients were profiled by liquid chromatography along with high-resolution mass spectrometry. Meanwhile, the metabolic characteristics of the PM-DILI were compared with that of autoimmune hepatitis (AIH), hepatitis B (HBV), and healthy volunteers. Twenty-four metabolites were identified to present significantly different levels in PM-DILI patients compared with HBV and AIH groups. These metabolites were enriched into glucose, amino acids, and sphingolipids metabolisms. Among these essential metabolites, the ratios of P-cresol sulfate vs. phenylalanine and inosine vs. bilirubin were further selected using a stepwise decision tree to construct a classification model in order to differentiate PM-DILI from HBV and AIH. The model was highly effective with sensitivity of 92.3% and specificity of 88.9%. This study presents an integrated view of the metabolic features of PM-DILI induced by herbal medicine, and the four-metabolite decision tree technique imparts a potent tool in clinical diagnosis.
Salivary metabolites are promising noninvasive biomarkers of drug-induced liver injury.
Yu S, Zheng H, Wang S, Rong W, Li P, Jing J World J Gastroenterol. 2024; 30(18):2454-2466.
PMID: 38764769 PMC: 11099387. DOI: 10.3748/wjg.v30.i18.2454.
He R, Gao S, Yao H, Zhao Z, Tong J, Zhang H Microbiol Spectr. 2023; 11(3):e0206722.
PMID: 37036349 PMC: 10269556. DOI: 10.1128/spectrum.02067-22.
Ravindra K, Vaidya V, Wang Z, Federspiel J, Virgen-Slane R, Everley R Nat Commun. 2023; 14(1):1215.
PMID: 36869085 PMC: 9984368. DOI: 10.1038/s41467-023-36858-6.
Fu H, Xu J, Ai X, Dang F, Tan X, Yu H Cells. 2022; 11(23).
PMID: 36497042 PMC: 9736483. DOI: 10.3390/cells11233782.
The Potential Role of Metabolomics in Drug-Induced Liver Injury (DILI) Assessment.
Moreno-Torres M, Quintas G, Castell J Metabolites. 2022; 12(6).
PMID: 35736496 PMC: 9227129. DOI: 10.3390/metabo12060564.